Literature DB >> 28863095

How Can We Optimize Antibiotic Use in the PICU?

Kathleen Chiotos1, Jeffrey S Gerber, Adam S Himebauch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28863095      PMCID： PMC6054310          DOI： 10.1097/PCC.0000000000001261

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN： 1529-7535            Impact factor:   3.624


× No keyword cloud information.
  15 in total

1.  Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.

Authors:  Anand Kumar; Daniel Roberts; Kenneth E Wood; Bruce Light; Joseph E Parrillo; Satendra Sharma; Robert Suppes; Daniel Feinstein; Sergio Zanotti; Leo Taiberg; David Gurka; Aseem Kumar; Mary Cheang
Journal:  Crit Care Med       Date:  2006-06       Impact factor: 7.598

2.  The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America.

Authors:  Brad Spellberg; Robert Guidos; David Gilbert; John Bradley; Helen W Boucher; W Michael Scheld; John G Bartlett; John Edwards
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

3.  Use of antibiotics in pediatric intensive care and potential savings.

Authors:  J E Fischer; M Ramser; S Fanconi
Journal:  Intensive Care Med       Date:  2000-07       Impact factor: 17.440

Review 4.  Review of rapid diagnostic tests used by antimicrobial stewardship programs.

Authors:  Karri A Bauer; Katherine K Perez; Graeme N Forrest; Debra A Goff
Journal:  Clin Infect Dis       Date:  2014-10-15       Impact factor: 9.079

5.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.

Authors:  Andrew Rhodes; Laura E Evans; Waleed Alhazzani; Mitchell M Levy; Massimo Antonelli; Ricard Ferrer; Anand Kumar; Jonathan E Sevransky; Charles L Sprung; Mark E Nunnally; Bram Rochwerg; Gordon D Rubenfeld; Derek C Angus; Djillali Annane; Richard J Beale; Geoffrey J Bellinghan; Gordon R Bernard; Jean-Daniel Chiche; Craig Coopersmith; Daniel P De Backer; Craig J French; Seitaro Fujishima; Herwig Gerlach; Jorge Luis Hidalgo; Steven M Hollenberg; Alan E Jones; Dilip R Karnad; Ruth M Kleinpell; Younsuck Koh; Thiago Costa Lisboa; Flavia R Machado; John J Marini; John C Marshall; John E Mazuski; Lauralyn A McIntyre; Anthony S McLean; Sangeeta Mehta; Rui P Moreno; John Myburgh; Paolo Navalesi; Osamu Nishida; Tiffany M Osborn; Anders Perner; Colleen M Plunkett; Marco Ranieri; Christa A Schorr; Maureen A Seckel; Christopher W Seymour; Lisa Shieh; Khalid A Shukri; Steven Q Simpson; Mervyn Singer; B Taylor Thompson; Sean R Townsend; Thomas Van der Poll; Jean-Louis Vincent; W Joost Wiersinga; Janice L Zimmerman; R Phillip Dellinger
Journal:  Crit Care Med       Date:  2017-03       Impact factor: 7.598

6.  Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program.

Authors:  Ricard Ferrer; Ignacio Martin-Loeches; Gary Phillips; Tiffany M Osborn; Sean Townsend; R Phillip Dellinger; Antonio Artigas; Christa Schorr; Mitchell M Levy
Journal:  Crit Care Med       Date:  2014-08       Impact factor: 7.598

7.  Point prevalence survey of antimicrobial utilization in the cardiac and pediatric critical care unit.

Authors:  Ekaterina Blinova; Elaine Lau; Ari Bitnun; Peter Cox; Steven Schwartz; Eshetu Atenafu; Yvonne Yau; Laurie Streitenberger; Christopher S Parshuram; John Marshall; Winnie Seto
Journal:  Pediatr Crit Care Med       Date:  2013-07       Impact factor: 3.624

8.  A negative nares screen in combination with absence of clinical risk factors can be used to identify patients with very low likelihood of methicillin-resistant Staphylococcus aureus infection in a Veterans Affairs hospital.

Authors:  Sadao Jinno; Shelley Chang; Curtis J Donskey
Journal:  Am J Infect Control       Date:  2012-02-10       Impact factor: 2.918

9.  Impact of regular collaboration between infectious diseases and critical care practitioners on antimicrobial utilization and patient outcome.

Authors:  Ramzy H Rimawi; Mark A Mazer; Dawd S Siraj; Mike Gooch; Paul P Cook
Journal:  Crit Care Med       Date:  2013-09       Impact factor: 7.598

10.  Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.

Authors:  Evelien de Jong; Jos A van Oers; Albertus Beishuizen; Piet Vos; Wytze J Vermeijden; Lenneke E Haas; Bert G Loef; Tom Dormans; Gertrude C van Melsen; Yvette C Kluiters; Hans Kemperman; Maarten J van den Elsen; Jeroen A Schouten; Jörn O Streefkerk; Hans G Krabbe; Hans Kieft; Georg H Kluge; Veerle C van Dam; Joost van Pelt; Laura Bormans; Martine Bokelman Otten; Auke C Reidinga; Henrik Endeman; Jos W Twisk; Ewoudt M W van de Garde; Anne Marie G A de Smet; Jozef Kesecioglu; Armand R Girbes; Maarten W Nijsten; Dylan W de Lange
Journal:  Lancet Infect Dis       Date:  2016-03-02       Impact factor: 25.071
View more
  1 in total

1.  Association of Endotracheal Aspirate Culture Variability and Antibiotic Use in Mechanically Ventilated Pediatric Patients.

Authors:  Andrea Prinzi; Sarah K Parker; Cary Thurm; Meghan Birkholz; Anna Sick-Samuels
Journal:  JAMA Netw Open       Date:  2021-12-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.